Business Paid
Moderna locates all operational facilities for its expansion in Warsaw
17:59
The COVID-19 pandemic has accelerated the development of mRNA-based vaccines. In line with its new strategy, Moderna – a global pioneer in mRNA technology – wants to bring vaccines for the 15 viruses most dangerous to humans into clinical trials by 2025. Accelerating work in this area entails developing infrastructure and operational facilities.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
